On January 29, 2020 Varian (NYSE: VAR) reported it has signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment at its clinics (Press release, Varian Medical Systems, JAN 29, 2020, View Source [SID1234553655]). Five of the systems will replace existing non-Varian systems, one will replace an existing Varian system and one will be placed in a new vault. Installation of the systems is expected to begin in late 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"We are honored Massachusetts General selected the Varian radiotherapy and radiosurgery systems for its cancer center," said John Kowal, president Varian Oncology Systems for the Americas. "We look forward to collaborating with the clinical team on the installation and use of these new systems and together helping create a world without fear of cancer."

Varian’s family of medical linear accelerators incorporate numerous technical innovations including dynamically synchronized imaging, patient positioning, motion management, and treatment delivery during a radiotherapy or radiosurgery procedure.